KC
GILD icon

Kepos Capital’s Gilead Sciences GILD Stock Holding History

Kepos Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-15,835
Closed -$1.03M – 227
2019
Q4 		$1.03M Sell
15,835
-63
-0.4% -$4.1K 0.1% 123
2019
Q3 		$1.01M Buy
+15,898
New +$1.04M 0.1% 111
2019
Q1 		– Sell
-105,041
Closed -$6.57M – 360
2018
Q4 		$6.57M Buy
105,041
+30,650
+41% +$2.14M 0.51% 40
2018
Q3 		$5.74M Buy
+74,391
New +$5.62M 0.29% 85
2018
Q2 		– Sell
-55,946
Closed -$4.22M – 340
2018
Q1 		$4.22M Sell
55,946
-9,589
-15% -$762K 0.25% 92
2017
Q4 		$4.7M Buy
65,535
+26,041
+66% +$1.98M 0.42% 45
2017
Q3 		$3.2M Buy
+39,494
New +$3.02M 0.54% 26

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Kepos Capital's GILD Position: Q1 2020 in Review

Kepos Capital sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 15,835 shares — an estimated $1.03M sold.

Kepos Capital first reported a position in GILD in Q3 2017 and held it in 7 quarters. The position peaked at $6.57M in Q4 2018. 1,643 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • Kepos Capital reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
  • Kepos Capital sold 15,835 Gilead Sciences shares in Q1 2020, an estimated $1.03M.
  • Kepos Capital first reported a position in Gilead Sciences in Q3 2017 and held it in 7 quarters.
  • Kepos Capital's Gilead Sciences position peaked at $6.57M in Q4 2018.
  • 1,643 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on Kepos Capital's 13F filing for Q1 2020, filed 12 May 2020.